Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 13 studies | 37% ± 19% | |
| cardiac muscle cell | 6 studies | 82% ± 13% | |
| astrocyte | 6 studies | 38% ± 11% | |
| retina horizontal cell | 5 studies | 54% ± 16% | |
| GABAergic neuron | 3 studies | 23% ± 1% | |
| epithelial cell | 3 studies | 22% ± 4% | |
| basal cell | 3 studies | 23% ± 1% | |
| glutamatergic neuron | 3 studies | 36% ± 9% | |
| fibroblast | 3 studies | 28% ± 15% | |
| smooth muscle cell | 3 studies | 31% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 98% | 3141.94 | 639 / 653 | 94% | 8.48 | 571 / 605 |
| prostate | 87% | 2503.37 | 212 / 245 | 84% | 3.39 | 421 / 502 |
| kidney | 87% | 1876.24 | 77 / 89 | 73% | 4.15 | 659 / 901 |
| breast | 63% | 3434.41 | 291 / 459 | 91% | 9.48 | 1018 / 1118 |
| uterus | 95% | 5746.71 | 161 / 170 | 49% | 2.40 | 225 / 459 |
| bladder | 81% | 2528.05 | 17 / 21 | 58% | 3.99 | 293 / 504 |
| ovary | 99% | 12306.98 | 178 / 180 | 38% | 0.92 | 165 / 430 |
| muscle | 100% | 377653.06 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.33 | 1 / 1 |
| heart | 100% | 73959.45 | 857 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 37% | 830.00 | 539 / 1445 | 42% | 1.14 | 76 / 183 |
| brain | 18% | 271.59 | 467 / 2642 | 51% | 2.74 | 362 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 4.41 | 31 / 45 |
| skin | 49% | 1240.73 | 893 / 1809 | 7% | 0.19 | 32 / 472 |
| lung | 9% | 218.52 | 54 / 578 | 43% | 1.01 | 495 / 1155 |
| intestine | 38% | 733.08 | 371 / 966 | 5% | 0.08 | 25 / 527 |
| liver | 14% | 232.68 | 31 / 226 | 29% | 0.74 | 119 / 406 |
| pancreas | 1% | 7.82 | 2 / 328 | 36% | 0.93 | 64 / 178 |
| stomach | 21% | 431.33 | 76 / 359 | 11% | 0.29 | 31 / 286 |
| adipose | 25% | 511.18 | 301 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 10% | 0.15 | 8 / 80 |
| blood vessel | 7% | 398.70 | 88 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 8.48 | 1 / 258 | 4% | 0.17 | 10 / 230 |
| peripheral blood | 1% | 56.25 | 11 / 929 | 0% | 0 | 0 / 0 |
| spleen | 0% | 5.41 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0031430 | Cellular component | M band |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016529 | Cellular component | sarcoplasmic reticulum |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| Gene name | CMYA5 |
| Protein name | Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) |
| Synonyms | C5orf10 DTNBP2 SPRYD2 TRIM76 |
| Description | FUNCTION: May serve as an anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) via binding to PRKAR2A (By similarity). May function as a repressor of calcineurin-mediated transcriptional activity. May attenuate calcineurin ability to induce slow-fiber gene program in muscle and may negatively modulate skeletal muscle regeneration (By similarity). Plays a role in the assembly of ryanodine receptor (RYR2) clusters in striated muscle (By similarity). . |
| Accessions | Q8N3K9 ENST00000446378.3 |
